Partnering opportunities for a small biotech firm for the development of the gene therapy
The company was small and wanted to collaborate with the company that had a viral vector technology platform with product in pre-clinical to phase I. The most important thing for the company was the smarter allocation of company funds.
- Due Diligence to identify the platforms
- Prioritisation of Technology platforms
- Level 1, Level 2 and Level 3 Screening and Company Profiling
- Matrix Analysis
- To further understand the technology, developmental goals, commercialization perspective and possible deal and milestone aspirations
- Provided 20 Potential ready to partner Companies